Compare LFS & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LFS | MYO |
|---|---|---|
| Founded | 2001 | 2004 |
| Country | Japan | United States |
| Employees | 1055 | N/A |
| Industry | Other Consumer Services | Industrial Specialties |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 54.2M | 44.8M |
| IPO Year | N/A | 2017 |
| Metric | LFS | MYO |
|---|---|---|
| Price | $2.32 | $1.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $7.67 |
| AVG Volume (30 Days) | ★ 722.6K | 387.6K |
| Earning Date | 04-08-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,000,000,000.00 |
| Revenue This Year | N/A | $9.10 |
| Revenue Next Year | N/A | $13.59 |
| P/E Ratio | $25.19 | ★ N/A |
| Revenue Growth | N/A | ★ 40814.79 |
| 52 Week Low | $1.58 | $0.61 |
| 52 Week High | $12.49 | $1.84 |
| Indicator | LFS | MYO |
|---|---|---|
| Relative Strength Index (RSI) | 57.89 | 65.39 |
| Support Level | $2.16 | $0.92 |
| Resistance Level | $2.74 | N/A |
| Average True Range (ATR) | 0.30 | 0.11 |
| MACD | 0.03 | 0.03 |
| Stochastic Oscillator | 18.78 | 80.23 |
Leifras Co Ltd is a sports and social business company dedicated to youth sports and community engagement. It provide services related to the organization and operations of sports schools and sports events for children. The company focuses on covering 13 sports like soccer, basketball, and dance and in child athletic development, club activity management for schools, and social businesses like elderly care.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA). Geographically, it derives maximum revenue from the United States, followed by Germany, and other international.